Owing to this heterogeneity of symptomatic manifestations, sometimes even within the same family, ATP1A3-related neurologic disorders are now considered a clinical continuum and have a wide range of severity, age of onset, and progression of different signs and symptoms [15,16]. Here, ATP1A3 is linked to nervous system disorder.